India approves Johnson & Johnson COVID-19 vaccine for emergency use

Indian Health Ministry has approved Johnson & Johnson's single-dose COVID-19 vaccine for emergency use.

Ekleme: 07.08.2021 17:25:52 / Güncelleme: 07.08.2021 17:25:52 / English News
Destek için 

“India expands its vaccine basket! Johnson and Johnson’s single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has 5 EUA vaccines. This will further boost our nation's collective fight against COVID19,” said the country’s Health Minister Mansukh Mandaviya in a tweet on Saturday.

However, Johnson & Johnson said it was too early to give a delivery timeline.

The company applied for emergency use approval of its vaccine on Friday.

The shot will be brought to India through a supply agreement with homegrown vaccine maker Biological E Ltd, the company said.

Currently, India has the largest number of confirmed cases in Asia. As of 7 August 2021, India has the second-highest number of confirmed cases in the world (after the United States) with 31,897,413 reported cases of COVID-19 infection and the third-highest number of COVID-19 deaths (after the United States and Brazil) at 427,488 deaths. (ILKHA)